Suppr超能文献

人工β细胞(生物调节器)用于不稳定型糖尿病患者的调节——20个月后的结果

The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.

作者信息

Beyer J, Wolf E, Cordes U, Hassingen W

出版信息

Horm Metab Res Suppl. 1979(8):127-31.

PMID:395068
Abstract

In 55 poorly controlled insulin-dependent diabetics, we tried to discover criteria for an improvement of metabolism by means of the "artificial beta-cell" (Biostator). To this end, during the first 24 h of hospitalization, blood glucose was monitored continuously under conventional insulin therapy (monitoring period). Insulin requirement was determined during the next 24 h by the artificial beta-cell (feedback period). Corrections of diabetes regimen were made with reference to the insulin consumption during the feedback period and to the extent of the postprandial blood sugar increases and decreases during the monitoring period. The resulting new diabetes regimen led to a significant improvement of the daily blood sugar profiles.

摘要

在55名胰岛素依赖型糖尿病控制不佳的患者中,我们试图通过“人工β细胞”(生物调节器)来发现改善代谢的标准。为此,在住院的头24小时内,在常规胰岛素治疗下持续监测血糖(监测期)。在接下来的24小时内通过人工β细胞确定胰岛素需求量(反馈期)。根据反馈期的胰岛素消耗量以及监测期餐后血糖升高和降低的程度对糖尿病治疗方案进行调整。由此产生的新糖尿病治疗方案使每日血糖曲线得到显著改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验